PL4181693T3 - Suplement diety do stosowania w sposobie ochrony wątroby przed skutkami stosowania metotreksatu jako leku chemioterapeutycznego, zawierający dihydromirycetynę, cholinę oraz jedną lub więcej witamin o aktywności przeciwutleniającej - Google Patents

Suplement diety do stosowania w sposobie ochrony wątroby przed skutkami stosowania metotreksatu jako leku chemioterapeutycznego, zawierający dihydromirycetynę, cholinę oraz jedną lub więcej witamin o aktywności przeciwutleniającej

Info

Publication number
PL4181693T3
PL4181693T3 PL21746134.2T PL21746134T PL4181693T3 PL 4181693 T3 PL4181693 T3 PL 4181693T3 PL 21746134 T PL21746134 T PL 21746134T PL 4181693 T3 PL4181693 T3 PL 4181693T3
Authority
PL
Poland
Prior art keywords
dihydromyricetin
methotrexate
choline
vitamins
liver
Prior art date
Application number
PL21746134.2T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. filed Critical Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Publication of PL4181693T3 publication Critical patent/PL4181693T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/02—Antioxidant
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts
    • A23V2250/2116—Flavonoids, isoflavones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds
    • A23V2250/304—Choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/708—Vitamin C
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/712—Vitamin E

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL21746134.2T 2020-07-14 2021-07-09 Suplement diety do stosowania w sposobie ochrony wątroby przed skutkami stosowania metotreksatu jako leku chemioterapeutycznego, zawierający dihydromirycetynę, cholinę oraz jedną lub więcej witamin o aktywności przeciwutleniającej PL4181693T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20200100411A GR1010117B (el) 2020-07-14 2020-07-14 Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου διυδρομυρισετινης, χολινης και μιας ή περισσοτερων βιταμινων με αντιοξειδωτικη δραση, χρησιμων για τη φυσιολογικη λειτουργια του ηπατος
PCT/GR2021/000046 WO2022013581A1 (en) 2020-07-14 2021-07-09 Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function

Publications (1)

Publication Number Publication Date
PL4181693T3 true PL4181693T3 (pl) 2025-12-08

Family

ID=77051073

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21746134.2T PL4181693T3 (pl) 2020-07-14 2021-07-09 Suplement diety do stosowania w sposobie ochrony wątroby przed skutkami stosowania metotreksatu jako leku chemioterapeutycznego, zawierający dihydromirycetynę, cholinę oraz jedną lub więcej witamin o aktywności przeciwutleniającej

Country Status (9)

Country Link
EP (1) EP4181693B1 (pl)
ES (1) ES3042405T3 (pl)
GR (1) GR1010117B (pl)
HR (1) HRP20251212T1 (pl)
HU (1) HUE073056T2 (pl)
PL (1) PL4181693T3 (pl)
RS (1) RS67290B1 (pl)
SM (1) SMT202500390T1 (pl)
WO (1) WO2022013581A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115177612A (zh) * 2022-08-01 2022-10-14 杭州凤禾植物科技有限公司 一种具有增发作用的组合物
FR3161530A1 (fr) * 2024-04-30 2025-10-31 Selvia Ingredient alimentaire a but nutritionnel a base de bitartrate de choline pouvant etre utilise en substitut de sel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003084531A1 (de) * 2002-04-10 2003-10-16 Haemato-Basics Gmbh Vitamin-kombination zum schutz bei chemo- oder/und strahlungstherapie maligner tumoren
WO2012027326A2 (en) 2010-08-24 2012-03-01 The Regents Of The University Of California Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
CN102775455A (zh) 2011-05-13 2012-11-14 贵州省生物研究所 一种治疗急慢性支气管炎的二氢杨梅素药物及其制备方法
CA2878914A1 (en) 2012-07-13 2014-01-16 Phyto Tech Corp. Compositions and methods of treating hair loss and delaying aging of skin
US9211298B2 (en) * 2012-11-16 2015-12-15 Song Gao Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
CN104116730A (zh) 2013-04-26 2014-10-29 中国科学院大连化学物理研究所 二氢杨梅素作为活性成份在制备帕金森症治疗药物中的应用
TW201605357A (zh) * 2013-11-29 2016-02-16 梅茲製藥有限兩合公司 減緩酒精有害效應之組成物和膳食補充劑及其應用
CN103751173A (zh) * 2014-01-06 2014-04-30 广东医学院附属医院 一种二氢杨梅素在制备肝再生药物中的应用
US20160158305A1 (en) * 2014-09-19 2016-06-09 Chip E. Thomson Additives and supplements
ES2919874T3 (es) 2014-09-24 2022-07-28 Vital Beverages Global Inc Composiciones y métodos para el suministro selectivo en el tubo gastrointestinal
EP3278793A1 (de) * 2016-08-04 2018-02-07 ppsph. GmbH Zusammensetzung zur behandlung von veisalgia
WO2018134713A1 (en) 2017-01-21 2018-07-26 R&R Salons Pvt. Ltd. Hair growth retardant composition
CN107468832A (zh) * 2017-08-24 2017-12-15 佛山市益丰年生物科技有限公司 一种养肝保肝组合物及其制备方法
US11096904B2 (en) 2018-05-11 2021-08-24 Linda J. Kaplan Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia

Also Published As

Publication number Publication date
GR1010117B (el) 2021-11-08
RS67290B1 (sr) 2025-11-28
WO2022013581A1 (en) 2022-01-20
EP4181693C0 (en) 2025-09-03
HRP20251212T1 (hr) 2025-12-19
EP4181693A1 (en) 2023-05-24
HUE073056T2 (hu) 2025-12-28
EP4181693B1 (en) 2025-09-03
SMT202500390T1 (it) 2025-11-10
ES3042405T3 (en) 2025-11-20

Similar Documents

Publication Publication Date Title
Jayakumar et al. In-vitro and in-vivo antioxidant effects of the oyster mushroom Pleurotus ostreatus
HUE073056T2 (hu) Táplálékkiegészítõ a májnak kemoterápiás gyógyszerként alkalmazott metotrexát hatásai elleni védelmére szolgáló eljárásban való alkalmazásra, amely dihidromiricetint, kolint és egy vagy több antioxidáns hatású vitamint tartalmaz
IL174184A0 (en) Stable beadlets of lipophilic nutrients
WO2018231943A3 (en) COMPOSITIONS AND METHODS FOR IMPROVING CHEMOTHERAPY TREATMENT OF CANCER
MX2026000074A (es) Composiciones de fibra soluble de superoxido dismutasa
SG170042A1 (en) Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives
EP3279210A4 (en) Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient
HUE060933T2 (hu) 2'-fukozil-laktózt és élelmi butirátot tartalmazó táplálékkészítmény
CY1108314T1 (el) Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος
AU2003214059A1 (en) Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
Wang et al. Dietary modulators of statin efficacy in cardiovascular disease and cognition
EP2415358A3 (de) Nahrungsergänzungsmittelpräparat, welches eine Steviakomponente enthält
EA201400600A1 (ru) Биологически активная добавка к пище
CL2020002369A1 (es) Preparación farmacéutica o de complemento alimenticio a base de alfa-lactoalbúmina
WO2006089211A3 (en) Combat/training antioxidant micronutrient formulation and method of administration
WO2005117863A3 (en) Non-steroid anti-inflammatory agents with vitamins, minerals, and dietary supplements for the prevention and treatment of primary, secondary and tertiary cancer
GB2613695B (en) Lollipop for the administration of pharmaceuticals, food supplements and nutraceuticals
GB202105574D0 (en) Nutritional supplement and uses
Splenda Falling Food Prices Raise Hopes for 25th World Food Day
HK40015881A (en) Nutraceutical, dietetic and nutritional composition with antioxidant activity
Larijani et al. Effects of vitamin E on growth, survival and fecundity of zebrafish (Danio rerio)
Randi VIEW
HK40016597A (en) Medicinal compounds and nutritional supplements
GB201617931D0 (en) Adaptive media combined with foods, functional foods, vitamins, supplements and medicines
TH12736A3 (th) ผลิตภัณฑ์อาหารเสริมสำหรับป้องกันหรือรักษาโรคเบาหวาน